Document Detail

Hypertension in women.
MedLine Citation:
PMID:  8665426     Owner:  NLM     Status:  MEDLINE    
Hypertension in women has received little attention in comparison to men. There are only a handful of studies focusing on women with hypertension. Nevertheless, the data provide some information on the prevalence of hypertension in women, complications and the effectiveness of treatment. The Framingham Study showed that blood pressure (BP) increased with age in both men and women. The Hypertension Detection and Follow-up Program study demonstrated that hypertension was much more prevalent in men than women. However, in the postmenopausal group more than half were hypertensive. High BP is prevalent in older women. In absolute values, the complication rate is lower in women than in men but increases with age. At all levels of BP, the morbidity and mortality associated with BP is lower in women than men. Nevertheless, there is a five- to sixfold increase in risk in hypertensive compared with normotensive women. Furthermore, hypertensive women with a myocardial infarction have a worse prognosis than men. No study data using newer agents such as calcium channel blockers and angiotensin-converting enzyme inhibitors are available yet. Since antihypertensive treatment appears to be effective in smokers, cessation of smoking is a very important intervention. Studies such as the European Working Party on Hypertension in Elderly, Systolic Hypertension in Elderly, Swedish Trial of Old Patients with Hypertension, and Medical Research Council 1992 have recruited patients 60 years of age and older, mainly women. These trials have shown that in the elderly hypertensive all-cause mortality is reduced by 30%, stroke by 33%, congestive heart disease mortality by 20% and heart failure by 40% to 50% with treatment. However, even these newer trials have used the so-called "old medications'. Studies using "newer drugs' are in progress.
N M Robitaille
Related Documents :
24311706 - Kidney stones and cardiovascular events: a cohort study.
24655696 - Temporal trends in clinical characteristics of patients without known cardiovascular di...
24717946 - Prevalence, risk factors and comorbidities of allergic rhinitis in south korea: the fif...
24219756 - Early peak height velocity and cardiovascular disease mortality among icelandic women.
16967756 - What do women know about the risks of delayed childbearing?
19209006 - Changes in prevalence and incidence of parkinson's disease in japan during a quarter of...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  12 Suppl D     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-08-05     Completed Date:  1996-08-05     Revised Date:  2008-04-09    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  6D-8D     Citation Subset:  IM    
Institut de cardiologie de Québec, Hôpital Laval, Ste-Foy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Distribution
Antihypertensive Agents / therapeutic use
Follow-Up Studies
Hypertension* / epidemiology,  etiology,  prevention & control
Middle Aged
Sex Distribution
Smoking / adverse effects
Treatment Outcome
Women's Health*
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of the social environment on blood pressure in women.
Next Document:  Women, hormones and blood pressure.